4//SEC Filing
Lachey Jennifer 4
Accession 0001209191-22-042573
CIK 0001664710other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:40 PM ET
Size
8.6 KB
Accession
0001209191-22-042573
Insider Transaction Report
Form 4
Lachey Jennifer
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-07-15$0.30/sh+46,034$13,810→ 141,134 total - Sale
Common Stock
2022-07-15$30.00/sh−46,034$1,381,020→ 95,100 total - Exercise/Conversion
Employee Stock Option (right to buy)
2022-07-15−46,034→ 8,755 totalExercise: $0.30Exp: 2028-03-25→ Common Stock (46,034 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Immediately exercisable.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001808322
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:40 PM ET
- Size
- 8.6 KB